Covered recipient · General Payments record
THOMAS P EVANS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,916.59
- Reported across 343 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $596.62 | 44 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $175.03 | 14 |
| ABBVIE INC. | $139.93 | 15 |
| Novo Nordisk AS | $93.07 | 5 |
| Merck Sharp & Dohme Corporation | $39.81 | 2 |
| Lilly USA, LLC | $31.05 | 2 |
| Supernus Pharmaceuticals, Inc. | $22.29 | 1 |
| Acerta Pharma LLC | $21.81 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.37 | 1 |
| GlaxoSmithKline, LLC. | $19.98 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.67 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (44)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.13 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702936 | CMS |
| ABBVIE INC. | $12.13 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702938 | CMS |
| ABBVIE INC. | $5.63 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702940 | CMS |
| ABBVIE INC. | $5.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702942 | CMS |
| ABBVIE INC. | $2.02 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702944 | CMS |
| ABBVIE INC. | $9.14 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702946 | CMS |
| ABBVIE INC. | $21.30 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702948 | CMS |
| ABBVIE INC. | $6.14 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702950 | CMS |
| ABBVIE INC. | $6.03 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702952 | CMS |
| ABBVIE INC. | $15.65 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702954 | CMS |
| ABBVIE INC. | $5.39 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702956 | CMS |
| ABBVIE INC. | $5.47 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702958 | CMS |
| ABBVIE INC. | $6.42 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702960 | CMS |
| ABBVIE INC. | $11.97 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702962 | CMS |
| ABBVIE INC. | $21.68 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103702964 | CMS |
| Amgen Inc. | $11.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117550071 | CMS |
| Amgen Inc. | $18.99 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609224 | CMS |
| Amgen Inc. | $13.17 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609194 | CMS |
| Amgen Inc. | $15.69 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609232 | CMS |
| Amgen Inc. | $15.99 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609240 | CMS |
| Amgen Inc. | $12.27 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609248 | CMS |
| Amgen Inc. | $3.85 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609259 | CMS |
| Amgen Inc. | $10.84 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609267 | CMS |
| Amgen Inc. | $3.81 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609202 | CMS |
| Amgen Inc. | $11.85 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609210 | CMS |
| Amgen Inc. | $17.10 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117550073 | CMS |
| Amgen Inc. | $12.53 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115609218 | CMS |
| Amgen Inc. | $10.30 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117550075 | CMS |
| Amgen Inc. | $16.71 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117550077 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.81 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104452378 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.61 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118177080 | CMS |
| GlaxoSmithKline, LLC. | $19.98 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116151435 | CMS |
| Lilly USA, LLC | $15.72 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135465432 | CMS |
| Lilly USA, LLC | $15.33 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135465434 | CMS |
| Merck Sharp & Dohme LLC | $18.24 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141966963 | CMS |
| Merck Sharp & Dohme LLC | $21.57 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141644293 | CMS |
| Novo Nordisk Inc | $18.94 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096608196 | CMS |
| Novo Nordisk Inc | $17.88 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097208087 | CMS |
| Novo Nordisk Inc | $18.76 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097033419 | CMS |
| Novo Nordisk Inc | $19.37 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096613932 | CMS |
| Novo Nordisk Inc | $18.12 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096812484 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.37 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118890486 | CMS |
| Supernus Pharmaceuticals, Inc. | $22.29 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147893659 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.67 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151555000 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.